This inventor holds 27 USPTO granted patents and 12 published patent applications, plus 5 CIPO patents and 1 EPO patent, primarily in Vaccine Development. Top assignees: Nabi, Nabi Biopharmaceuticals, Inc., Nanobio Corporation. Active years: 1998-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Rockville, MD (US) (1998 - 2012)
- Ann Arbor, MI (US) (2016 - 2021)
- St. Louis, MO (US) (2023)
Company Filing History:
10 out of 11 
10 out of 13 
4 out of 10 
Years Active: 1998-2023
Areas of Expertise:
Title: The Innovative Mind of Ali Ibrahim Fattom
Introduction
Ali Ibrahim Fattom, based in Rockville, MD, is a prolific inventor recognized for his significant contributions to the fields of nicotine addiction treatment and smoking cessation. With an impressive portfolio of 21 patents, Fattom has dedicated his career to developing innovative solutions aimed at improving public health.
Latest Patents
Among his latest patents are notable inventions that focus on smoking cessation. One of these is the "Smoking Cessation Kit and Method," which comprises innovative devices and kits designed to determine the optimal time for individuals to quit smoking. This method also extends the duration of smoking abstinence based on serum levels of anti-nicotine antibodies, providing a scientific approach to combat nicotine addiction.
Another significant patent is for "Hapten-carrier Conjugates for Treating and Preventing Nicotine Addiction." These novel conjugates are designed to induce the production of specific antibodies against nicotine in vivo. The conjugates maintain the original chirality of nicotine in its (S)-(-) state and exhibit excellent stability properties. They hold great potential for formulating vaccines aimed at preventing and treating nicotine addiction through both active and passive immunization methods.
Career Highlights
Throughout his career, Fattom has worked with reputable organizations such as Nabi and Nabi Biopharmaceuticals, Inc. His innovative spirit has not only advanced scientific understanding but has also opened new avenues in therapeutic interventions for nicotine addiction.
Collaborations
Fattom has collaborated with esteemed professionals in his field, including Robert B. Naso and Sofiane Ennifar. These collaborations have undoubtedly played a pivotal role in the success of his research and the development of his patented inventions.
Conclusion
Ali Ibrahim Fattom continues to be a vital figure in the battle against nicotine addiction, employing his expertise in immunology and pharmacology to create effective solutions. His work not only contributes to the scientific community but also impacts countless lives by promoting healthier choices through innovative cessation methods.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile